XRF Scientific Forward P/E
The Forward P/E Ratio of XRF Scientific (XRF.AX) as of Sep 7, 2026 is 28.64. In the previous year, Forward P/E Ratio was 33.47 — a change of -14.43% (lower).
Get this data via API
Financial Data API
Forward P/E
28.64
YoY
-14.43%
Last updated:
The XRF Scientific Forward P/E history
3 Years
10 Years
25 Years
Max
| YEAR | Forward P/E | YoY |
|---|---|---|
| 28.64 | -14.43% | |
| 33.47 | -13.50% | |
| 38.70 | -20.84% | |
| 48.89 | -15.67% | |
| 57.97 | -39.16% | |
| 95.28 | -31.52% | |
| 139.14 | -52.10% | |
| 290.45 | -22.48% | |
| 374.68 | +93.66% | |
| 193.47 | +71.70% | |
| 112.68 | -7.56% | |
| 121.89 | — |
XRF Scientific Stock analysis
Frequently Asked Questions about XRF Scientific stock
Forward P/E Ratio of XRF Scientific is 28.64 in 2026.
Forward P/E Ratio of XRF Scientific changed from 33.47 to 28.64, representing a -14.43% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Forward P/E Ratio XRF Scientific since 2006 – with annual values, charts, and detailed analysis.
The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.
To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's XRF Scientific with sector peers and the industry average to assess whether it is attractive.
Valuation — XRF Scientific
All Key Metrics — XRF Scientific
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth